Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q3 2023
Institutional positions in Jasper Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −5 vs. Q2 2023
- Shares held
- 91.5M
- +3.46M (+3.9%) vs. Q2 2023
- Total value
- $63.7M
- −$56.3M (−46.9%) vs. Q2 2023
- New holders
- 7
- 11 more added
- Sold out
- 12
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 11,219,036 | $7.59M | 6.20% | 00.0% | Unchanged |
| BVF Inc | 9,900,000 | $6.93M | 0.19% | 00.0% | Unchanged |
| Carlyle Group Inc. | 8,761,891 | $6.05M | 0.26% | 00.0% | Unchanged |
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $5.96M | 7.92% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 8,300,980 | $5.81M | 0.59% | +525,000+6.8% | Added |
| Sphera Funds Management Ltd. | 5,687,134 | $3.98M | 0.96% | +1,413,126+33.1% | Added |
| Franklin Resources Inc | 4,500,217 | $3.15M | 0.00% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 4,468,114 | $3.13M | 0.55% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,792,958 | $2.66M | 0.00% | +104,600+2.8% | Added |
| Bank of America Corp | 3,180,301 | $2.23M | 0.00% | +928,205+41.2% | Added |
| Ally Bridge Group (NY) LLC | 3,144,164 | $2.20M | 2.58% | +626,932+24.9% | Added |
| Kingdon Capital Management, L.L.C. | 3,040,000 | $2.13M | 0.39% | 00.0% | Unchanged |
| Woodline Partners LP | 3,000,000 | $2.10M | 0.02% | 00.0% | Unchanged |
| Altium Capital Management LP | 2,868,000 | $2.01M | 1.16% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 2,402,904 | $1.68M | 0.21% | −74,976−3.0% | Reduced |
| Saturn V Capital Management LLC | 1,387,015 | $970.9K | 0.41% | +1,387,015 | New |
| BlackRock Inc. | 1,320,784 | $924.5K | 0.00% | −11,563−0.9% | Reduced |
| Ikarian Capital, LLC | 1,125,087 | $787.6K | 0.29% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 904,477 | $633.3K | 0.00% | −61,027−6.3% | Reduced |
| Morgan Stanley | 780,879 | $546.6K | 0.00% | +459,329+142.8% | Added |
| Mariner, LLC | 652,749 | $456.9K | 0.00% | −62,247−8.7% | Reduced |
| Scoggin Management LP | 508,045 | $355.6K | 0.48% | +508,045 | New |
| Fernwood Investment Management, LLC | 454,706 | $318.3K | 0.11% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 310,212 | $217.0K | 0.00% | +252,112+433.9% | Added |
| Boothbay Fund Management, LLC | 233,159 | $163.2K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 229,994 | $161.0K | 0.00% | +30,900+15.5% | Added |
| Cowen and Company, LLC | 200,393 | $140.3K | 0.01% | +200,393 | New |
| Northern Trust Corp | 154,909 | $108.4K | 0.00% | 00.0% | Unchanged |
| Forefront Analytics, LLC | 110,792 | $77.6K | 0.04% | +41,425+59.7% | Added |
| Citadel Advisors LLC | 78,326 | $54.8K | 0.00% | −1,347,696−94.5% | Reduced |
| Two Sigma Investments, LP | 66,093 | $46.3K | 0.00% | +66,093 | New |
| Summit Trail Advisors, LLC | 65,000 | $45.5K | 0.00% | +65,000 | New |
| Millennium Management LLC | 62,308 | $43.6K | 0.00% | +43,880+238.1% | Added |
| Bank of New York Mellon Corp | 43,593 | $30.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 36,899 | $25.8K | 0.00% | 00.0% | Unchanged |
| Gries Financial LLC | 23,845 | $16.7K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 11,140 | $7.00K | 0.00% | +11,140 | New |
| Wells Fargo & Company | 749 | $524 | 0.00% | −48−6.0% | Reduced |
| FMR LLC | 100 | $70 | 0.00% | +100 | New |
| Group One Trading, L.P. | 1 | $1 | 0.00% | −8,291−100.0% | Reduced |
| Cutler Group LP | 1,200 | $0 | 0.00% | +300+33.3% | Added |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −489,884−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −476,948−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −41,263−100.0% | Sold out |
| One68 Global Capital, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,286−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,940−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9,397−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −924−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −249−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −260−100.0% | Sold out |